Description
Manufacturer and provider of pharmaceutical products. The company's pharmaceutical products include development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients, enabling clients to get quality and cost effective pharmaceutical products.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3999514-A1 | Crystalline lorlatinib : fumaric acid and solid state form thereof | Pending | 18-Jul-2019 | 0000000000 | |
EP-3830184-A1 | Solid state forms of sugammadex sodium | Pending | 02-Aug-2018 | 000000000 | |
US-20210292479-A1 | Solid state forms of sugammadex sodium | Pending | 02-Aug-2018 | 000000000 | |
EP-3784675-A1 | Solid state forms of lorlatinib and their preparation | Pending | 23-Apr-2018 | 0000000000 | |
US-20210163498-A1 | Solid state forms of lorlatinib and their preparation | Pending | 23-Apr-2018 | C07D498/18 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Željko Čović | Chief Executive Officer | ||
Mihael Furjan | President | ||
Nikolina Čehulić | Chief Financial Officer | ||
Matko Bolanča | Chief Executive Officer |